Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dishman Of India Rejects World Bank Financing For Planned Expansion

This article was originally published in PharmAsia News

Executive Summary

India's Dishman Pharmaceuticals says it has rejected World Bank conditions for new financing for the firm, opting instead to try other means to raise funds to support its expansion plans. Medical Director J.R. Vyas said his company did not like the World Bank conditions. Funds are needed to support Dishman's five-year expansion plan that include developing new products and building new facilities in India and China. The firm also plans to strengthen its subsidiaries and enter into various joint ventures. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067482

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel